COMMUNIQUÉS West-GlobeNewswire

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress
04/09/2026
AUSTIN, Texas, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis [...]
Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms
04/09/2026
First large-scale, single-molecule analysis of the tau proteoform landscape reveals unique disease-associated modifications, a new source of potential biomarkers and drug targets, and a method Nautilus is now extending [...]
Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis
04/09/2026
Charging Robotics is one of the few worldwide developing innovative wireless charging systems designed specifically for automated parking facilities and autonomous mobile platforms- environments where conventional [...]
Glass House Brands to Participate in Upcoming September Investor Conferences
04/09/2026
LONG BEACH, Calif. and TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (NYSE: GLAS), one of the fastest-growing cannabis companies in the U.S., [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2026
SAN DIEGO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that on September [...]
Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
04/09/2026
WALTHAM, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
04/09/2026
Mr. Willener brings more than three decades of global capital markets and corporate finance experience to support advancement of the Company’s pipeline of potential best-in-class therapies led by its BiTAC® platform [...]
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
04/09/2026
Additions extend BioStem's hospital channel to its BioRetain® wound care line POMPANO BEACH, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading [...]
INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives
04/09/2026
Follow-up to the Company’s July 29, July 30 and August 10, 2026 announcements NEW YORK and TOKYO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) (“Instinct Bio” or the “ [...]
Immuron to launch PROIBS® in the United States
04/09/2026
MELBOURNE, Australia, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to announce that it has executed an exclusive distribution agreement for PROIBS® in the United States with [...]
Supporting the continued long-term and stable ownership of Coloplast
04/09/2026
Coloplast has been informed that the Danish Financial Supervisory Authority (FSA) has today announced that it has notified Niels Peter Louis-Hansen that it has granted an exemption from the obligation to make a [...]
Raeliva Announces Rebrand and Expansion of Online Wellness Platform Beyond GLP-1 Care
04/09/2026
SAN DIEGO, CA, Sept. 04, 2026 (GLOBE NEWSWIRE) -- After building its initial patient base through online GLP-1 care under the OnlineSemaglutide.org brand, telehealth provider Raeliva is entering its next chapter with an [...]
Tangram Therapeutics annonce le passage aux cohortes de patients dans l’essai de phase 1/2 RESTORE-MASH évaluant le TGM-312 et la nomination du Dr Sonya Montgomery au poste de directrice du développement
04/09/2026
LONDRES, 04 sept. 2026 (GLOBE NEWSWIRE) -- Tangram Therapeutics ( « Tangram » ), société spécialisée dans le développement de médicaments innovants fondés sur l’ARNi visant à améliorer de manière significative la vie [...]
C4X Discovery to receive milestone payment for NRF2 exclusive worldwide license agreement
04/09/2026
4 September 2026 – C4X Discovery Holdings Ltd (“C4XD”), a pioneering Drug Discovery company, today announces that it will receive a $13 million milestone payment from AstraZeneca [LON: AZN], triggered by the entry of [...]
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
04/09/2026
COPENHAGEN, Denmark, September 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 285,900 as a consequence of employees’ exercise of warrants. [...]
102,000 Orion Corporation A shares converted into B shares
04/09/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 4 SEPTEMBER 2026 at 9.00 EEST 102,000 Orion Corporation A shares converted into B shares In accordance with [...]
Persica Pharmaceuticals publishes new analyses of antibiotic exposure-response, reinforcing the scientific case for PP353 in vertebrogenic Lumbar Back Pain
04/09/2026
The publication builds on Phase 1b PP353 data published in The Lancet's eClinicalMedicine, further supporting the rationale for a targeted, non-opioid approach to vertebrogenic Lumbar Back Pain Manuscript has been [...]
ONWARD Medical to Announce First-Half 2026 Results on September 9, 2026
04/09/2026
EINDHOVEN, the Netherlands, Sept. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
New Copenhagen facility to strengthen Europe's quantum manufacturing capabilities
04/09/2026
COPENHAGEN, Denmark, Sept. 04, 2026 (GLOBE NEWSWIRE) -- The state-of-the-art quantum facility will strengthen Europe’s ability to design, manufacture and scale next-generation quantum chips, helping to position the [...]

Pages